Clinical trial
A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
This study will evaluate the efficacy and safety of OC5 in patients with PH.
Study Type: Interventional (Clinical Trial)
Actual Enrollment: 25 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Phase III Double-blind, Randomised Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
Actual Study Start Date: January 9, 2018
Estimated Primary Completion Date: April 2021
Estimated Study Completion Date: April 2021
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Expected enrolment | 25 |
| Actual Study start date | 09 January 2018 |
| Estimated Study Completion Date | 01 April 2021 |